Lipitension – myth or reality? Opinion of a practicing cardiologist (letter to the editor) von Kashtalap, V. V.

Volltext

Therapy for hypertension and dyslipidemia: potential of Lipertans (on the example of a clinical observation) von Kashtalap, V. V.

Volltext

Single-pill combination of indapamide and perindopril: potential of practical application von Kochergina, A. M., Kashtalap, V. V.

Volltext

Endothelial protective effect of pitavastatin von Berns, A. S., Kashtalap, V. V.

Volltext

Do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization? von Barbarash, O L, Kashtalap, V V

Volltext

Remote active monitoring of patients after myocardial infarction: are there any advantages over standard outpatient monitoring? von D. Yu. Sedykh, T. S. Alkhimova, V. V. Kashtalap, O. L. Barbarash

Volltext

The role of psycho-emotional factors in assessing the prognosis of different types of myocardial infarction von Kinash, V. I., Kashtalap, V. V., Vorobiev, A. S., Urvantseva, I. A., Kovalenko, L. V.

Volltext

Risk management in patients with atrial fibrillation and comorbid conditions: potentialities of edoxaban von Barbarash, O. L., Kashtalap, V. V.

Volltext

Methodological characteristics of the academic competition for general practitioners, family doctors and internists as a type of informal education von Astanina, S. Yu, Berns, S. A., Gilyarevsky, S. R., Gorban, V. V., Druk, I. V., Dzhioeva, O. N., Kashtalap, V. V., Chesnikova, A. I., Chmykhova, E. V., Shaporova, N. L., Shepel, R. N., Yavelov, I. S., Drapkina, O. M.

Volltext

Cardiovascular Comorbidity: Patient with Coronary Artery Disease and Peripheral Artery Atherosclerosis. How to Identify and Manage the Risks of Ischemic Events? von Barbarash, O. L., Kashtalap, V. V., Shibanova, I. A.

Volltext

Management of ischemic risk events in patients with multifocal atherosclerosis and type 2 diabetes mellitus von Barbarash, O. L., Kashtalap, V. V.

Volltext

Combined use of the GRACE ACS risk score and comorbidity indices to increase the effectiveness of hospital mortality risk assessment in patients with acute coronary syndrome von Zykov, Mikhail V., Dyachenko, Nikita V., Velieva, Rufana M., Kashtalap, Vasily V., Barbarash, Olga L.

Volltext

Intensification of lipid-lowering therapy in very high-risk patients: potential of combination with PCSK9 inhibitors von Sedykh, D. Yu, Kashtalap, V. V., Khryachkova, O. N., Petrova, T. S., Barbarash, O. L.

Volltext

Relationship between lipid disorders and severity and nature of coronary artery lesions in male patients with coronary artery disease von Kashtalap, V, Barbarash, O, Hryachkova, O, Novitskaya, A

Volltext

A Rational Approach to a De-Escalation of Double Antithrombotic Therapy: The Possibilities of Clopidogrel von Kashtalap, V. V., Barbarash, O. L.

Volltext

Socio-economic and behavioral «portrait» of patients with myocardial infarction von Barbarash, O. L., Sedykh, D. Yu, Petrova, T. S., Hryachkova, O. N., Kashtalap, V. V., Artamonova, G. V.

Volltext

Regional differences in cardiac mortality rates in Russia: the role of statistical features von Drapkina, O. M., Samorodskaya, I. V., Yavelov, I. S., Kashtalap, V. V., Barbarash, O. I.

Volltext

Healthy nutrition in secondary prevention after myocardial infarction. What to focus on? von Barbarash, O. L., Sedykh, D. Yu, Petrova, T. S., Kashtalap, V. V., Tsygankova, D. P.

Volltext

Clopidogrel as a part of double disaggregant therapy in ACS: a reasonable choice in complex clinical situations von Kashtalap, V. V., Barbarash, O. L.

Volltext

Interleukin-12 serum level has prognostic value in patients with ST-segment elevation myocardial infarction von Zykov, Mikhail V., MD, PhD, Barbarash, Olga L., MD, PhD, Kashtalap, Vasiliy V., MD, PhD, Kutikhin, Anton G., MD, Barbarash, Leonid S., MD, PhD

Volltext